Evaluation of bioaccumulation and toxic effect of aluminum and molybdenum oxide nanoparticles used as an active component of bactericidal agents

Cover Page

Cite item

Full Text

Abstract

Introduction. Nanoparticles (NPs) of aluminum oxide (Al2O3) and molybdenum oxide (MoO3) have the potential to be used as an active component of bactericidal agents. At the same time, there is information in the scientific literature about the negative effects of these NPs on organism. Given that, it seems relevant to perform the study and comparative analysis of the toxicity of Al2O3 and MoO3 NPs.

Materials and methods. We examined physical properties of Al2O3 NPs and MoO3 NPs. In an experiment on Wistar rats, peculiarities of bioaccumulation and toxic action at multiply inhalation exposure was researched. 

Results. The examined samples were a nanomaterial judging by such parameters as particle size, shape, surface area and total pore volume. Under exposure to Al2O3 NPs, aluminum concentrations were statistically significant increase in the lungs, brain, liver and blood relative to the control; under exposure to MoO3 NPs — molybdenum concentration in heart, lungs, brain, kidney and blood. Under exposure to MoO3 NPs, a wider range of negative effects changed relative to the control of biochemical parameters (increased activity of ALP, LDH, concentrations of total and direct bilirubin, urea, creatinine) was established than during exposure to Al2O3 NPs (increased activity of ALT, AST, ALP, LDH, concentrations direct bilirubin). Pathomorphological changes were identified in the lungs, brain, heart and liver under exposure to Al2O3 NPs; in lungs, brain and liver under exposure to MoO3 NPs in the lungs. However, tissue changes upon exposure to MoO3 NPs are more pronounced than those upon exposure to Al2O3 NPs. 

Limitations. The study involved only multiple inhalation exposure to Al2O3 NPs and MoO3 NPs in an experiment on Wistar rats.

Conclusion. Differences in the toxicokinetics of Al2O3 and MoO3 NPs do not make it possible to single out among them those that are more dangerous for human health, and therefore additional studies are needed.

Compliance with ethical standards. The study was accomplished in accordance with the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (ETS No. 123) and requirements of the Local Committee on Ethics of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies (the Meeting Report No. 5 and 6 issued on January 20, 2021).

Conflict of interests. The author declares no conflict of interest.

Funding. The research was granted financial support from the federal budget.

Received: December 27, 2022 / Accepted: May 26, 2023 / Published: June 30, 2023

About the authors

Mark Sergeevich Stepankov

Federal Scientific Center for Medical and Preventive Health Risk Management Technologies

Author for correspondence.
Email: stepankov@fcrisk.ru

Graduate student, junior researcher of the Department of Biochemical and Сytogenetic Diagnostics of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies of Rospotrebnadzor, 614045, Perm, Russian Federation.

e-mail: stepankov@fcrisk.ru

Russian Federation

References

  1. Global nanomaterials market (2021 to 2029) – featuring BASF, Bayer and Chasm Technologies among others. Research and Markets. Available at: https://clck.ru/34jnqj (accessed 05.12.2022)
  2. Nanotechnology market – size, share, COVID impact analysis and forecast to 2027. Research and Markets. Available at: https://clck.ru/34kxtw (accessed 05.12.2022)
  3. Borodianskiy K., Zinigrad M. Nanomaterials applications in modern metallurgical processes. Diffusion Foundations. 2016; 9: 30–41. https://doi.org/10.4028/www.scientific.net/DF.9.30
  4. Neme K., Nafady A., Uddin S., et al. Application of nanotechnology in agriculture, postharvest loss reduction and food processing: food security implication and challenges. Heliyon. 2021; 7(12): 1–12. https://doi.org/10.1016/j.heliyon.2021.e08539
  5. Shafique M., Luo X. Nanotechnology in transportation vehicles: an overview of Its applications, environmental, health and safety concerns. Materials (Basel). 2019; 12(15): 1–32. https://doi.org/10.3390/ma12152493
  6. Salata O.V. Applications of nanoparticles in biology and medicine. J. Nanobiotechnology. 2004; 2(1): 1–6. https://doi.org/10.1186/1477-3155-2-3
  7. Xie G., Bai H., Miao G. The applications of ultra-thin nanofilm for aerospace advanced manufacturing technology. Nanomaterials (Basel). 2021; 11(12): 1–9. https://doi.org/10.3390/nano11123282
  8. Fu L., Liao K., Tang B. Applications of graphene and Its derivatives in the upstream oil and gas industry: a systematic review. Nanomaterials (Basel). 2020; 10(6): 1–31. https://doi.org/10.3390/nano10061013
  9. Shafiq M., Anjum S., Hano C., et al. An Overview of the Applications of Nanomaterials and Nanodevices in the Food Industry. Foods. 2020; 9(2): 1–27. https://doi.org/10.3390/foods9020148
  10. Piracha S., Saleem S., Momil et al. Nanoparticle: role in chemical industries, potential sources and chemical catalysis applications. Sch. Int. J. Chem. Mater. Sci. 2021; 4(4): 40–5. https://doi.org/10.36348/sijcms.2021.v04i04.006
  11. Rouch D.A., Lee B.T., Morby A.P. Understanding cellular responses to toxic agents: a model for mechanism‐choice in bacterial metal resistance. J. Ind. Microbiol. 1995; 14(2): 132–41. https://doi.org/10.1007/BF01569895
  12. Xu C., Akakuru O.U., Zheng J., Wu A. Applications of Iron Oxide-Based Magnetic Nanoparticles in the Diagnosis and Treatment of Bacterial Infections. Front. Bioeng. Biotechnol. 2019; 7: 1–17. https://doi.org/10.3389/fbioe.2019.00141
  13. Gold K., Slay B., Knackstedt M., Gaharwar A.K. Antimicrobial Activity of Metal and Metal-Oxide Based Nanoparticles. Adv. Ther. 2018; 1(3): 1–15. https://doi.org/10.1002/adtp.201700033
  14. Raghunath A., Perumal E. Metal oxide nanoparticles as antimicrobial agents: A promise for the future. Int. J. Antimicrob. Agents. 2017; 49: 137–52. https://doi.org/10.1016/j.ijantimicag.2016.11.011
  15. Susanty D., Haris M.S., Taher M., Khotib J. Natural Products-Based Metallic Nanoparticles as Antimicrobial Agents. Front. Pharmacol. 2022; 13: 1–14. https://doi.org/10.3389/fphar.2022.895616
  16. Sanchez-Lopez E., Gomes D., Esteruelas G., et al. Metal-Based Nanoparticles as Antimicrobial Agents: An Overview. Nanomaterials. 2020; 10(2): 1–39. https://doi.org/10.3390/nano10020292
  17. Gudkov S.V., Burmistrov D.E., Smirnova V.V. et al. A Mini Review of Antibacterial Properties of Al2O3 Nanoparticles. Nanomaterials. 2022; 12(15): 1–17. https://doi.org/10.3390/nano12152635
  18. Picarra S., Lopes E., Almeida P. Novel coating containing molybdenum oxide nanoparticles to reduce Staphylococcus aureus contamination on inanimate surfaces. PLoS One. 2019; 14(3): 1–11. https://doi.org/10.1371/journal.pone.0213151
  19. Dighore N., Jadhav S., Anandgaonker P., et al. Molybdenum Oxide Nanoparticles as Antimicrobial Agents. J. Clust. Sci. 2017; 28: 109–18. https://doi.org/10.1007/s10876-016-1048-1
  20. Indrakumar J., Korrapati P.S. Steering efficacy of nano molybdenum towards cancer: mechanism of action. Biol. Trace Elem. Res. 2020; 194(1): 121–34. https://doi.org/10.1007/s12011-019-01742-2
  21. Fakhri A., Nejad P.A. Antimicrobal, antioxidant and cytotoxic effect of molybdenum trioxide nanoparticles and application of this for degradation of ketamine under different light illumination. J. Photochem. Photobiol. B. 2016; 159: 211–7. https://doi.org/10.1016/j.jphotobiol.2016.04.002
  22. Arul Prakash F., Dushendra Babu G.J., Lavanya M., et al. Toxicity studies of aluminium oxide nanoparticles in cell lines. Int. J. Nanotech. Appl. 2011; 5(2): 99–107.
  23. El-Hussainy el-H.M., Hussein A.M., Abdel-Aziz A. et al. Effects of aluminum oxide (Al2O3) nanoparticles on ECG, myocardial inflammatory cytokines, redox state, and connexin 43 and lipid profile in rats: possible cardioprotective effect of gallic acid. Can. J. Physiol. Pharmacol. 2016; 94(8): 868–78. https://doi.org/10.1139/cjpp-2015-0446
  24. Sizova E.A., Miroshnikov S.A., Kalashnikov V.V. Morphological and biochemical parameters in Wistar rats influenced by molybdenum and its oxide nanoparticles. Sel’skohozyajstvennaya biologiya. 2016; 51(6): 929–36. https://doi.org/10.15389/agrobiology.2016.6.929rus (In Russian)
  25. Chen L., Yokel R., Henning B., et al. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J. Neuroimmune. Pharmacol. 2008; 3(4): 286–95. https://doi.org/10.1007/s11481-008-9131-5
  26. Pham-Huy L.A., He H., Pham-Huy C. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 2008; 4(2): 89–96.
  27. Phanindra A., Jestadi D.B., Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J. Clin. Biochem. 2015; 30(1): 11–26. https://doi.org/10.1007%2Fs12291-014-0446-0
  28. Božinović K., Nestić D., Centra U.G. et al. In-vitro toxicity of molybdenum trioxide nanoparticles on human keratinocytes. Toxicology. 2020; 444: 1–11. https://doi.org/10.1016/j.tox.2020.152564
  29. Sirajuddin A., Raparia K., Lewis V.A., et al. Primary pulmonary lymphoid lesions: radiologic and pathologic findings. Radiographics. 2016; 36(1): 53–70. https://doi.org/10.1148/rg.2016140339
  30. Kaptein F.H.J., Kroft L.J.M., Hammerschlag G., et al. Pulmonary infarction in acute pulmonary embolism. Thromb. Res. 2021; 202: 162–9. https://doi.org/10.1016/j.thromres.2021.03.022
  31. Hsia C.C.W. Signals and mechanisms of compensatory lung growth. J. Appl. Physiol. 2004; 97(5): 1992–8. https://doi.org/10.1152/japplphysiol.00530.2004
  32. Braydich-Stolle L., Hussain S., Schlager J.J., Hoffman M.-C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. 2005; 88(2): 412–9. https://dx.doi.org/10.1093/toxsci/kfi256
  33. Strukov A.I., Serov V.V. Pathological anatomy a textbook [Patologicheskaya anatomiya: uchebnik]. Мoscow: Litterra; 2010 (In Russian)
  34. Abdelhalim M.A.K., Jarrar B.M. Gold nanoparticles induced cloudy swelling to hydropic degeneration, cytoplasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver. Lipids Health Dis. 2011; 10: 1–6. https://doi.org/10.1186/1476-511x-10-166
  35. Li Z.Z., Berk M., McIntyre T.M., Gores G.J., Feldstein A.E. The lysosomal-mitochondrial axis in free fatty acid–induced hepatic lipotoxicity. Hepatology. 2008; 47(5): 1495–503. https://doi.org/10.1002/hep.22183
  36. Carvajai S., Perramón M., Oró D. et al. Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease. Sci. Rep. 2019; 9(1): 1–21. https://doi.org/10.1038/s41598-019-49262-2
  37. Nazarenko G.I., Kishkun A.A. Clinical evaluation of laboratory results [Klinicheskaya ocenka rezul’tatov laboratornyh issledovanij]. Мoscow: Medicina; 2006. (In Russian)

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Stepankov M.S.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 81728 от 11 декабря 2013.